[HTML][HTML] Primaquine dose and the risk of haemolysis in patients with uncomplicated Plasmodium vivax malaria: a systematic review and individual patient data meta …
Background Primaquine radical cure is used to treat dormant liver-stage parasites and
prevent relapsing Plasmodium vivax malaria but is limited by concerns of haemolysis. We …
prevent relapsing Plasmodium vivax malaria but is limited by concerns of haemolysis. We …
[HTML][HTML] Primaquine dose and the risk of haemolysis in patients with uncomplicated Plasmodium vivax malaria: a systematic review and individual patient data meta …
M Rajasekhar, JA Simpson, B Ley, P Edler… - The Lancet Infectious …, 2023 - Elsevier
Background Primaquine radical cure is used to treat dormant liver-stage parasites and
prevent relapsing Plasmodium vivax malaria but is limited by concerns of haemolysis. We …
prevent relapsing Plasmodium vivax malaria but is limited by concerns of haemolysis. We …
Primaquine dose and the risk of haemolysis in patients with uncomplicated Plasmodium vivax malaria: a systematic review and individual patient data meta-analysis
M Rajasekhar, JA Simpson, B Ley… - The Lancet … - pubmed.ncbi.nlm.nih.gov
Background Primaquine radical cure is used to treat dormant liver-stage parasites and
prevent relapsing Plasmodium vivax malaria but is limited by concerns of haemolysis. We …
prevent relapsing Plasmodium vivax malaria but is limited by concerns of haemolysis. We …
[PDF][PDF] Primaquine dose and the risk of haemolysis in patients with uncomplicated Plasmodium vivaxmalaria: a systematic review and individual patient data meta …
M Rajasekhar, JA Simpson, B Ley, P Edler… - Lancet Infect …, 2024 - researchers.cdu.edu.au
Background Primaquine radical cure is used to treat dormant liver-stage parasites and
prevent relapsing Plasmodium vivax malaria but is limited by concerns of haemolysis. We …
prevent relapsing Plasmodium vivax malaria but is limited by concerns of haemolysis. We …
Primaquine dose and the risk of haemolysis in patients with uncomplicated Plasmodium vivax malaria: a systematic review and individual patient data meta-analysis.
M Rajasekhar, JA Simpson, B Ley, P Edler… - The Lancet. Infectious …, 2023 - europepmc.org
Background Primaquine radical cure is used to treat dormant liver-stage parasites and
prevent relapsing Plasmodium vivax malaria but is limited by concerns of haemolysis. We …
prevent relapsing Plasmodium vivax malaria but is limited by concerns of haemolysis. We …
Primaquine dose and the risk of haemolysis in patients with uncomplicated Plasmodium vivax malaria: a systematic review and individual patient data meta-analysis
M Rajasekhar, JA Simpson, B Ley, P Edler… - Lancet Infectious …, 2023 - ora.ox.ac.uk
Background: Primaquine radical cure is used to treat dormant liver-stage parasites and
prevent relapsing Plasmodium vivax malaria but is limited by concerns of haemolysis. We …
prevent relapsing Plasmodium vivax malaria but is limited by concerns of haemolysis. We …
[PDF][PDF] Primaquine dose and the risk of haemolysis in patients with uncomplicated Plasmodium vivaxmalaria: a systematic review and individual patient data meta …
M Rajasekhar, JA Simpson, B Ley, P Edler, CS Chu… - Lancet Infect Dis, 2024 - run.unl.pt
Background Primaquine radical cure is used to treat dormant liver-stage parasites and
prevent relapsing Plasmodium vivax malaria but is limited by concerns of haemolysis. We …
prevent relapsing Plasmodium vivax malaria but is limited by concerns of haemolysis. We …
[HTML][HTML] Primaquine dose and the risk of haemolysis in patients with uncomplicated Plasmodium vivax malaria: a systematic review and individual patient data meta …
M Rajasekhar, JA Simpson, B Ley, P Edler… - The Lancet. Infectious …, 2024 - ncbi.nlm.nih.gov
Background Primaquine radical cure is used to treat dormant liver-stage parasites and
prevent relapsing Plasmodium vivax malaria but is limited by concerns of haemolysis. We …
prevent relapsing Plasmodium vivax malaria but is limited by concerns of haemolysis. We …
Primaquine dose and the risk of haemolysis in patients with uncomplicated Plasmodium vivax malaria: a systematic review and individual patient data meta-analysis
M Rajasekhar, JA Simpson… - The Lancet Infectious …, 2024 - impressions.manipal.edu
Background: Primaquine radical cure is used to treat dormant liver-stage parasites and
prevent relapsing Plasmodium vivax malaria but is limited by concerns of haemolysis. We …
prevent relapsing Plasmodium vivax malaria but is limited by concerns of haemolysis. We …
Primaquine dose and the risk of haemolysis in patients with uncomplicated Plasmodium vivax malaria: a systematic review and individual patient data meta-analysis
WWARNWV Primaquine… - The Lancet …, 2023 - researchinformation.amsterdamumc …
Background: Primaquine radical cure is used to treat dormant liver-stage parasites and
prevent relapsing Plasmodium vivax malaria but is limited by concerns of haemolysis. We …
prevent relapsing Plasmodium vivax malaria but is limited by concerns of haemolysis. We …